首页|血清CEA、CA125、CA19-9、CA72-4水平对胰腺癌患者预后不良的预测价值

血清CEA、CA125、CA19-9、CA72-4水平对胰腺癌患者预后不良的预测价值

扫码查看
目的:探讨癌胚抗原(CEA)、糖类抗原(CA)125、CA19-9、CA72-4水平对胰腺癌患者预后不良的预测价值.方法:回顾性分析 2021 年 1 月至 2023 年 1 月该院收治的 73 例胰腺癌患者的临床资料,患者均采用FP方案(氟尿嘧啶+顺铂)化疗,根据化疗预后将其分为预后良好组 22 例和预后不良组 51 例.比较两组化疗前血清CEA、CA125、CA19-9、CA72-4 水平,采用Logistic回归分析各指标对预后不良的影响,采用受试者工作特征(ROC)曲线分析血清CEA、CA125、CA19-9、CA72-4 水平单独及联合检测对胰腺癌患者预后不良的预测价值.结果:化疗前,预后不良组血清CEA、CA125、CA19-9、CA72-4 水平均高于预后良好组,差异有统计学意义(P<0.05);Logistic回归分析显示,化疗前血清CEA、CA125、CA19-9、CA72-4水平升高均是胰腺癌患者预后不良的危险因素(P<0.05);ROC曲线分析结果显示,化疗前血清CEA、CA125、CA19-9、CA72-4 水平联合检测预测胰腺癌患者预后不良的曲线下面积为 0.889,预测价值高于单项指标检测.结论:血清CEA、CA125、CA19-9、CA72-4 水平升高是胰腺癌患者预后不良的危险因素,各指标联合检测对预后不良的预测价值高于单项指标检测.
Value of serum CEA,CA125,CA19-9 and CA72-4 levels in prediction of prognosis of patients with pancreatic cancer
Objective:To investigate predictive value of carcinoembryonic antigen(CEA),carbohydrate antigen(CA)125,CA19-9 and CA72-4 levels for poor prognosis in patients with pancreatic cancer.Methods:The clinical data of 73 patients with pancreatic cancer admitted to this hospital from January 2021 to January 2023 were retrospectively analyzed.All patients were treated with FP regimen(Fluorouracil and Cisplatin)chemotherapy.According to the prognosis of chemotherapy,they were divided into good prognosis group(22 cases)and poor prognosis group(51 cases).The levels of serum CEA,CA125,CA19-9 and CA72-4 before chemotherapy were compared between the two groups.Logistic regression was used to analyze the effect of each index on poor prognosis.The receiver operating characteristic(ROC)curve was used to analyze the predictive value of single detection and combine detection of serum CEA,CA125,CA19-9,and CA72-4 levels for poor prognosis in the patients with pancreatic cancer.Results:Before chemotherapy,the levels of serum CEA,CA125,CA19-9 and CA72-4 in the poor prognosis group were higher than those in the good prognosis group,and the differences were statistically significant(P<0.05).Logistic regression analysis showed that the elevated serum CEA,CA125,CA19-9 and CA72-4 levels before chemotherapy were risk factors for poor prognosis in the patients with pancreatic cancer(P<0.05).ROC curve analysis showed that the area under the curve of combined detection of serum CEA,CA125,CA19-9 and CA72-4 levels before chemotherapy in the prediction of poor prognosis of the patients with pancreatic cancer was 0.889,which was higher than that of single index detection.Conclusions:The elevated levels of serum CEA,CA125,CA19-9 and CA72-4 are risk factors for poor prognosis of the patients with pancreatic cancer after chemotherapy.Further,the predictive value of combined detection of each index for poor prognosis is higher than that of single index detection.

Carcinoembryonic antigenCarbohydrate antigen 125Carbohydrate antigen 19-9Carbohydrate antigen 72-4Pancreatic cancer

吴朋

展开 >

郑州市金水区总医院检验科,河南 郑州 450000

癌胚抗原 糖类抗原 125 糖类抗原 19-9 糖类抗原 72-4 胰腺癌

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(7)
  • 13